NCT06690281 2025-09-11
A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies
National Institutes of Health Clinical Center (CC)
Phase 2 Withdrawn
Clinical Trials
3 trialsNCT03748927 2020-03-26
Natural History Study of Children and Adults With Fibrolamellar Hepatocellular Carcinoma
National Institutes of Health Clinical Center (CC)
Withdrawn
NCT02599909 2018-09-20
Gut Microbiota in People With Hepatocellular Carcinoma (HCC)
National Institutes of Health Clinical Center (CC)
Withdrawn